Abstract
Paroxysmal nocturnal hemoglobinuria (PNH) is an acquired clonal hematopoietic stem cell disorder with its protean clinical manifestations. This is due to partial or complete absence of ‘glycophosphatidyl-inositol-anchor proteins’ (GPI-AP). The main aim of this review is to highlight various diagnostic modalities available, basic principle of each test and recent advances in the diagnosis of PNH. Recently among various tests available, the flow cytometry has become ‘the gold standard’ for PNH testing. In order to overcome the difficulties encountered by the testing and research laboratories throughout the world, International Clinical Cytometry Society has come up with guidelines regarding the indications for testing, protocol for sample collection, processing, panel of antibodies as well as gating strategies to be used, how to interpret the test and reporting format to be used. It is essential to test at least two GPI-linked markers on at least two different lineages particularly on red cells and granulocytes/monocytes. The fluorescent aerolysin combined with other monoclonal antibodies in multicolour flow cytometry offered an improved assay not only for diagnosis but also for monitoring of PNH clones. It is equally important to diagnose this rare entity with high index of suspicion.
Similar content being viewed by others
References
Parker C, Omine M, Richards S et al (2005) Diagnosis and management of paroxysmal nocturnal hemoglobinuria. Blood 106:3699–3709
Pu JJ, Brodsky RA (2011) Paroxysmal nocturnal hemoglobinuria from bench to bedside. Clin Transl Sci 4:219–224
Richards SJ, Hill A, Hillmen P (2007) Recent advances in the diagnosis, monitoring and management of patients with paroxysmal nocturnal haemoglobinuria. Cytom B Clin Cytom 72:291–298
Hill A, Richards S, Hillmen P (2007) Recent developments in the understanding and management of paroxysmal nocturnal hemoglobinuria. Br J Haematol 137:181–192
Brodsky RA (2008) Advances in the diagnosis and therapy of paroxysmal nocturnal hemoglobinuria. Blood Rev 22:65–74
Hu R, Mukhina GL, Piantadosi S et al (2005) PIG-A mutations in normal hematopoiesis. Blood 105:3848–3854
Prince GM, Nguyen M, Lazarus HM et al (1995) Peripheral blood harvest of unaffected CD34+ CD38− hematopoietic precursors in paroxysmal nocturnal hemoglobinuria. Blood 86:3381–3386
Zacks MA, Garg N (2006) Recent developments in the molecular, biochemical and functional characterization of GPI8 and the GPI-anchoring mechanisms. Mol Membr Biol 23:209–225
Bain BJ, Win N (2006) Acquired haemolytic anaemias. In: Lewis SM, Bain BJ and Bates I (eds) Dacie and Lewis Practical Haematology. Philadelphia; 10th ed, pp 239–266
Zupanska B, Bogdanik B, Pyl H (2002) A gel microtyping system for diagnosis of paroxysmal nocturnal hemoglobinuria. Immunohematology 18:9–12
Hall SE, Rosse WF (1996) The use of monoclonal antibodies and flow cytometry in the diagnosis of paroxysmal nocturnal hemoglobinuria. Blood 87:5332–5340
Madkaikar M, Gupta M, Jijina F, Ghosh K (2009) Paroxysmal nocturnal haemoglobinuria: diagnostic tests, advantages, & limitations. Eur J Hematol 83:503–511
Sutherland DR, Kuek N, Davidson J et al (2007) Diagnosing PNH with FLAER and multiparameter flow cytometry. Cytom B Clin Cytom 72:167–177
Sutherland R, Keeney M, Illingworth A (2012) Practical guidelines for the high-sensitivity detection and monitoring of paroxysmal nocturnal hemoglobinuria clones by flow cytometry. Cytom B Clin Cytom 82:195–208
Brodsky RA, Mukhina G, Li S et al (2000) Improved detection and characterization of paroxysmal nocturnal hemoglobinuria using florescent aerolysin. Am J Clin Pathol 114:459–466
Peghini PE, Fehr J (2005) Clinical evaluation of an aerolysin-based screening test for paroxysmal nocturnal hemoglobinuria. Cytom B Clin Cytom 67:13–18
Movalia MK, Weitz IC, Lim SH, Illingworth A (2011) Incidence of PNH clones by diagnostic code utilizing high sensitivity flow cytometry. Blood (Abstracts from the 2011 American Society of Hematology Annual Meeting) 118:Abstract 1033
Latour RP, Mary JY, Salanoubat C et al (2008) Paroxysmal nocturnal hemoglobinuria: natural history of disease subcategories. Blood 112:3099–3106
Schrezenmeier H, Muus P, Socie G et al (2014) Baseline characteristics and disease burden in patients in the International Paroxysmal Nocturnal Hemoglobinuria Registry. Haematologica 99:922–929
Mahapatra M, Singh PK, Agarwal M et al (2015) Epidemiology, clinico-haematological profile and management of aplastic anemia: AIIMS experience. J Assoc Physicians India 63:30–35
Wang SA, Pozdnyakova O, Jorgensen JL et al (2009) Detection of paroxysmal nocturnal hemoglobinuria clones in patients with myelodysplastic syndromes and related bone marrow diseases, with emphasis on diagnostic pitfalls and caveats. Haematologica 94:29–37
Mukhina GL, Buckley JT, Barber JP et al (2001) Multilineage glycosylphosphatidylinositol anchor deficient hematopoiesis in untreated aplastic anaemia. Br J Haematol 115:476–482
Sachdeva MU, Varma N, Chandra D et al (2015) Multiparameter FLAER-based flow cytometry for screening of paroxysmal nocturnal hemoglobinuria enhances detection rates in patients with aplastic anemia. Ann Hematol 94:721–728
Wang H, Chuhjo T, Yamazaki H et al (2001) Relative increase of granulocytes with a paroxysmal nocturnal hemoglobinuria phenotype in aplastic anemia patients: the high prevalence at diagnosis. Eur J Haematol 66:200–205
Wang H, Chuhjo T, Yasue S et al (2002) Clinical significance of a minor population of paroxysmal nocturnal hemoglobinuria-type cells in bone marrow failure syndrome. Blood 100:3897–3902
Agarwal R, Chapple P, Brown M et al (2015) Analysis of abnormal clones by the fluorescent aerolysin method in paroxysmal nocturnal haemoglobinuria and other marrow disorders. Int J Lab Hematol 37:14–21
Maciejewski JP, Rivera C, Kook H et al (2001) Relationship between bone marrow failure syndromes and the presence of glycophosphatidyl inositol anchored protein deficient clones. Br J Haematol 115:1015–1022
Young NS, Abkowitz JL, Luzzattoet L (2000) New insights into the pathophysiology of acquired cytopenias. Hematology Am Soc Hematol Educ Program, pp 18–38
Brodsky RA (2006) New insights into paroxysmal nocturnal hemoglobinuria. Hematology Am Soc Hematol Educ Program, pp 24–28
Bessler M, Hiken J (2008) The pathophysiology of disease in patients with paroxysmal nocturnal hemoglobinuria. Hematology Am Soc Hematol Educ Program, pp 104–108
Borowitz MJ, Craig FE, DiGuiseppe JA, On behalf of the Clinical Cytometry Society et al (2010) Guidelines for the diagnosis and monitoring of paroxysmal nocturnal hemoglobinuria and related disorders by flow cytometry. Cytom B Clin Cytom 78:211–230
Sharma VR (2013) Paroxysmal nocturnal hemoglobinuria: pathogenesis, testing and diagnosis. Clin Adv Hematol and Oncol. 11:2–8
Gupta R, Pandey P, Choudhry R et al (2007) A prospective comparison of four techniques for diagnosis of paroxysmal nocturnal hemoglobinuria. Int J Lab Hematol 29:119–126
Oelschlaegel U, Besson I, Arnoulet C et al (2001) A standardized flow cytometric method for screening paroxysmal nocturnal haemoglobinuria (PNH) measuring CD55 and CD59 expression on erythrocytes and granulocytes. Clin Lab Haematol 23:81–90
Piedras J, López-Karpovitch X (2000) Flow cytometric analysis of glycosylphosphatidylinositol–anchored proteins to assess paroxysmal nocturnal hemoglobinuria clone size. Cytometry 42:234–238
Hernandez-Campo PM, Almeida J, Sanchez ML et al (2006) Normal patterns of expression of glycosylphosphatidylinositol-anchored proteins on different subsets of peripheral blood cells: a frame of reference for the diagnosis of paroxysmal nocturnal hemoglobinuria. Cytom B Clin Cytom 70:71–81
Richards SJ, Whitby L, Cullen MJ et al (2009) Development and evaluation of a stabilized whole-blood preparation as a process control material for screening of paroxysmal nocturnal hemoglobinuria by flowcytometry. Cytom B Clin Cytom 76:47–55
Richards SJ, Rawston AC, Hillmen P (2000) Application of flow cytometry to the diagnosis of paroxysmal nocturnal hemoglobinuria. Cytometry 42:223–233
Richards SJ, Hillmen P (2002) Immunophenotypic analysis of PNH cells. Curr Protoc Cytom. doi:10.1002/0471142956.cy0611s20
Navenot JM, Muller JY, Blanchard D (1998) Investigation of the survival of paroxysmal nocturnal hemoglobinuria red cells through the immunophenotyping of reticulocytes. Transfusion 38:337–342
Ware RE, Rosse WF, Hall SE (1995) Immunophenotypic analysis of reticulocytes in paroxysmal nocturnal hemoglobinuria. Blood 86:1586–1589
Diep DB, Nelson KL, Raja SM et al (1998) Glycosylphosphatidylinositol anchors of membrane glycoproteins are binding determinants for the channel-forming toxin aerolysin. J Biol Chem 273:2355–2360
Brodsky RA, Mukhina GL, Nelson KL et al (1999) Resistance of paroxysmal nocturnal hemoglobinuria cells to the glycosylphosphatidylinositol-binding toxin aerolysin. Blood 93:1749–1756
Sreedharanunni S, Sachdeva MU, Bose P et al (2016) Frequency of Paroxysmal nocturnal hemoglobinuria clones by multiparametric flow cytometry in pediatric aplastic anemia patients of Indian Ethnic origin. Pediatr Blood Cancer 63:93–97
Parker CJ (2016) Update on the diagnosis and management of paroxysmal nocturnal hemoglobinuria. Hematology Am Soc Hematol Educ Program, pp 208–216
Sutherland DR, Acton E, Keeney M et al (2014) Use of CD157 in FLAER-based assays for high-sensitivity PNH granulocyte and PNH monocyte detection. Cytom B Clin Cytom 86:44–55
Weitz IC, Razavi P, Rochanda L et al (2012) Eculizumab therapy results in rapid and sustained decreases in markers of thrombin generation and inflammation in patients with PNH independent of its effects on hemolysis and microparticle formation. Thromb Res 130:361–368
Wanachiwanawin W, Siripanyaphinyo U et al (2006) A Cohort study of the nature of paroxysmal nocturnal hemoglobinuria clones and PIG-A mutations in patients with aplastic anemia. Eur J Haematol 76:502–509
Sugimori C, Mochizuki K, Qi Z et al (2009) Origin and fate of blood cells deficient in glycosylphosphatidylinositol-anchored protein among patients with bone marrow failure. Br J Haematol 147:102–112
Raza A, Ravandi F, Rastogi A et al (2014) A prospective multicentre study of paroxysmal nocturnal hemoglobinuria cells in patients with bone marrow failure. Cytom B Clin Cyto 86:175–182
Mayo VM, Mukhina GL, Garrett ES et al (2004) Natural history of paroxysmal nocturnal hemoglobinuria using modern diagnostic assays. Br J Haematol 126:133–138
Acknowledgements
Currently Dr. Prabhu Manivannan is working as Assistant Professor in the department of Pathology, JIPMER, Puducherry would like to extend his acknowledgement to all laboratory technicians and Dr. Roopam Deka (Senior Resident), All India Institute of Medical Sciences (AIIMS), New Delhi for their dedicated work and for contributing CD157 plot for this manuscript. He would also like to acknowledge his wife Mrs. Manjari for final proof-reading of this manuscript. Dr. (Lt. Col) Ankur Ahuja is currently working as Assistant Professor in the department of Laboratory services, Army hospital Research and Referral, New Delhi. He would like to acknowledge his department as well as the hospital for letting him to contribute to this manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
None.
Rights and permissions
About this article
Cite this article
Manivannan, P., Ahuja, A. & Pati, H.P. Diagnosis of Paroxysmal Nocturnal Hemoglobinuria: Recent Advances. Indian J Hematol Blood Transfus 33, 453–462 (2017). https://doi.org/10.1007/s12288-017-0868-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12288-017-0868-y